The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity.
Fernie, Bruce A, Maher-Edwards, Lorraine, Murphy, Gabrielle et al. · Clinical psychology & psychotherapy · 2015 · DOI
Quick Summary
Researchers created a new questionnaire called the MaSCS to measure how people with ME/CFS think about their symptoms—specifically, how much they focus on symptoms and what they believe about controlling them. They tested this questionnaire with 124 ME/CFS patients and found it reliably measured two types of thinking: positive beliefs about symptom control and negative beliefs about symptom control. Both types of thinking were linked to how severe fatigue was, even when accounting for anxiety and depression.
Why It Matters
Understanding how ME/CFS patients think about and focus on their symptoms may help explain why symptoms persist and worsen. This validated questionnaire could help clinicians better assess individual patients and may guide development of cognitive-behavioral treatments tailored to address unhelpful thought patterns in ME/CFS.
Observed Findings
A two-factor model best fit the data, distinguishing positive from negative metacognitions about symptoms control.
Both positive and negative metacognitions were significantly correlated with fatigue levels in ME/CFS patients.
Metacognitions about symptoms control significantly predicted fatigue severity independent of anxiety and depression scores.
Both factors demonstrated good internal consistency, suggesting reliable measurement.
The sample was predominantly female (77%), limiting generalizability to male patients.
Inferred Conclusions
Metacognitive beliefs about symptom control play a meaningful role in ME/CFS symptom experience and may be important intervention targets.
The MaSCS is a reliable and valid first-generation instrument for assessing metacognitions in ME/CFS.
Clinical assessment and treatment formulation in ME/CFS may be improved by explicitly evaluating and addressing metacognitive processes.
Metacognitions about symptoms appear to be distinct from, but related to, anxiety and depression in ME/CFS.
Remaining Questions
Do positive and negative metacognitions about symptoms have different treatment implications, or do they operate through the same mechanism?
What This Study Does Not Prove
This study establishes correlation between metacognitions and fatigue severity, not causation—it does not prove that changing these thoughts will reduce symptoms. The cross-sectional design cannot determine whether negative metacognitions cause worse fatigue or result from it. Findings are preliminary and require replication in larger, more diverse samples before clinical implementation.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →